Advanced Therapy Developers Urged To Monitor Major EU Proposal On Using Blood, Tissues & Cells
Executive Summary
Companies have the opportunity to tell the European Commission what they think about its proposed regulation that would overhaul the rules governing the use of substances of human origin.